Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug Shipments Into U.S. Could Depend On Facility Inspection; FDA Mulls Import Alerts

Executive Summary

Foreign drug manufacturers may face refusal of their products at the U.S. border if they do not submit to an FDA inspection, another part of the agency’s growing effort to increase oversight of the global marketplace.

You may also be interested in...



U.S. FDA Globalization Efforts Gain Traction Even As Budget Request Emphasizes Old Inspection Model

U.S. FDA would gain a boost in funding for overseas manufacturing facility inspections in President Obama's fiscal year 2012 budget, even though the agency has acknowledged its model is unsustainable and is planning changes

FDA Globalization Efforts Gain Traction Even As Budget Request Emphasizes Old Inspection Model

FDA would gain a boost in funding for overseas manufacturing facility inspections in President Obama’s fiscal year 2012 budget, even though the agency has acknowledged its model is unsustainable and is planning changes.

FDA Globalization Efforts Gain Traction Even As Budget Request Emphasizes Old Inspection Model

FDA would gain a boost in funding for overseas manufacturing facility inspections in President Obama’s fiscal year 2012 budget, even though the agency has acknowledged its model is unsustainable and is planning changes.

Related Content

Topics

UsernamePublicRestriction

Register

ID1125791

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel